Lifecore Biomedical, Inc. De (LFCR) EPS (Weighted Average and Diluted) (2010 - 2025)

Lifecore Biomedical's EPS (Weighted Average and Diluted) history runs 16 years deep, the most recent figure standing at -$0.03 for Q2 2025.

• In Q2 2025, EPS (Weighted Average and Diluted) rose 84.21% year-over-year to -$0.03; the TTM figure through May 2025 stood at -$1.23 (down 592.0% YoY), while the FY2025 annual figure was -$1.27, down 588.46% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.03 for Q2 2025 at Lifecore Biomedical, up from -$0.42 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.4 in Q1 2024 to a low of -$1.88 in Q2 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.45 across 5 years, with a median of -$0.32 in 2021.
• The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) tumbled 6166.67% in 2022, then soared 225.81% in 2023.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.31 in 2021, then soared by 76.34% to -$0.31 in 2022, then jumped by 225.81% to $0.39 in 2023, then slumped by 164.1% to -$0.25 in 2024, then soared by 88.0% to -$0.03 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.03 (Q2 2025), -$0.42 (Q1 2025), and -$0.25 (Q4 2024), per Business Quant data.